Ask AI
H.R. 3866

Anabolic Steroid Control Act of 2004

(This measure has not been amended since it was reported to the House on April 27, 2004. The summary of that version is repeated here.)

Anabolic Steroid Control Act of 2004 - Amends: (1) the Controlled Substances Act to subject an offense of manufacturing, distributing, or possessing with intent to distribute an anabolic steroid within 1,000 feet of a sports facility to twice the maximum penalty otherwise imposed for a controlled substance violation; and (2) the Anabolic Steroid Control Act of 1990 to modify the definition of "anabolic steroid" to include certain steroid precursors (including tetrahydrogestrinone (THG) and androstenedione) and to exclude dehydroepiandrosterone.

Directs the U.S. Sentencing Commission to review the Federal sentencing guidelines with respect to offenses involving anabolic steroids and consider amending such guidelines to provide for increased penalties.

Authorizes the Attorney General, upon the recommendation of the Secretary of Health and Human Services, to exempt from regulation under the Controlled Substances Act any compound, mixture, or preparation that contains any anabolic steroid that is intended for administration to a human being or an animal and that does not present any significant potential for abuse because of its concentration, preparation, formulation, or delivery system.

Directs the Secretary to prepare and submit a report to the House and Senate Judiciary Committees and the House Committee on Energy and Commerce evaluating the health risks associated with dietary supplements not scheduled under this Act which contain substances similar to those added to the list of controlled substances under this Act, including recommendations on whether such substances should be regulated as anabolic steroids.

Received in the Senate and Read twice and referred to the Committee on the Judiciary.

Rep. Sensenbrenner, F. James, Jr. [R-WI-5](R-WI)Sponsor
9 cosponsors5 D4 R
9cosponsors3committees31actions1related bills22subjects
  1. IntroReferral

    Received in the Senate and Read twice and referred to the Committee on the Judiciary.

    Judiciary Committee
  2. FloorH38310

    Motion to reconsider laid on the table Agreed to without objection.

  3. FloorH37300

    On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 408 - 3 (Roll no. 226). (text: CR 6/2/2004 H3660-3661)

  4. Floor8000

    Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 408 - 3 (Roll no. 226).(text: CR 6/2/2004 H3660-3661)

  5. FloorH30000

    Considered as unfinished business. (consideration: CR H3740-3741)

  6. FloorH37220

    At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.

  7. FloorH8D000

    DEBATE - The House proceeded with forty minutes of debate on H.R. 3866.

  8. FloorH30000

    Considered under suspension of the rules. (consideration: CR H3660-3665)

  9. FloorH30300

    Mr. Sensenbrenner moved to suspend the rules and pass the bill, as amended.

  10. CalendarsH12410

    Placed on the Union Calendar, Calendar No. 270.

  11. CommitteeH12200

    Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 108-461, Part II.

    Energy and Commerce Committee
  12. Committee5000

    Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 108-461, Part II.

    Energy and Commerce Committee
  13. CommitteeH19000

    Ordered to be Reported (Amended) by Voice Vote.

    Energy and Commerce Committee
  14. CommitteeH15000-B

    Committee Consideration and Mark-up Session Held.

    Energy and Commerce Committee
  15. CommitteeH25000

    Subcommittee on Health Discharged.

    Energy and Commerce Committee
  16. IntroReferralH11210

    House Committee on Energy and Commerce Granted an extension for further consideration ending not later than April 27, 2004.

    Energy and Commerce Committee
  17. CommitteeH12200

    Reported (Amended) by the Committee on Judiciary. H. Rept. 108-461, Part I.

    Judiciary Committee
  18. Committee5000

    Reported (Amended) by the Committee on Judiciary. H. Rept. 108-461, Part I.

    Judiciary Committee
  19. CommitteeH27200

    Mr. Boehner asked unanimous consent that the Committee on Judiciary have until midnight on April 2 to file a report on H.R. 3866. Agreed to without objection.

    Judiciary Committee
  20. CommitteeH19000

    Ordered to be Reported (Amended) by Voice Vote.

    Judiciary Committee
  21. CommitteeH15000-B

    Committee Consideration and Mark-up Session Held.

    Judiciary Committee
  22. CommitteeH23000

    Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote.

    Crime and Federal Government Surveillance Subcommittee
  23. CommitteeH22000

    Subcommittee Consideration and Mark-up Session Held.

    Crime and Federal Government Surveillance Subcommittee
  24. CommitteeH21000

    Subcommittee Hearings Held.

    Crime and Federal Government Surveillance Subcommittee
  25. CommitteeH11000

    Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.

    Crime and Federal Government Surveillance Subcommittee
  26. CommitteeH11000

    Referred to the Subcommittee on Health, for a period to be subsequently determined by the Chairman.

    Health Subcommittee
  27. IntroReferralH11100

    Referred to the Committee on the Judiciary, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    Energy and Commerce Committee
  28. IntroReferralH11100-A

    Referred to the Committee on the Judiciary, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

  29. IntroReferralH11100

    Referred to the Committee on the Judiciary, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    Judiciary Committee
  30. IntroReferralIntro-H

    Introduced in House

  31. IntroReferral1000

    Introduced in House

Jun 3, 200436

(This measure has not been amended since it was reported to the House on April 27, 2004. The summary of that version is repeated here.)

Anabolic Steroid Control Act of 2004 - Amends: (1) the Controlled Substances Act to subject an offense of manufacturing, distributing, or possessing with intent to distribute an anabolic steroid within 1,000 feet of a sports facility to twice the maximum penalty otherwise imposed for a controlled substance violation; and (2) the Anabolic Steroid Control Act of 1990 to modify the definition of "anabolic steroid" to include certain steroid precursors (including tetrahydrogestrinone (THG) and androstenedione) and to exclude dehydroepiandrosterone.

Directs the U.S. Sentencing Commission to review the Federal sentencing guidelines with respect to offenses involving anabolic steroids and consider amending such guidelines to provide for increased penalties.

Authorizes the Attorney General, upon the recommendation of the Secretary of Health and Human Services, to exempt from regulation under the Controlled Substances Act any compound, mixture, or preparation that contains any anabolic steroid that is intended for administration to a human being or an animal and that does not present any significant potential for abuse because of its concentration, preparation, formulation, or delivery system.

Directs the Secretary to prepare and submit a report to the House and Senate Judiciary Committees and the House Committee on Energy and Commerce evaluating the health risks associated with dietary supplements not scheduled under this Act which contain substances similar to those added to the list of controlled substances under this Act, including recommendations on whether such substances should be regulated as anabolic steroids.

Apr 27, 200417

Anabolic Steroid Control Act of 2004 - Amends: (1) the Controlled Substances Act to subject an offense of manufacturing, distributing, or possessing with intent to distribute an anabolic steroid within 1,000 feet of a sports facility to twice the maximum penalty otherwise imposed for a controlled substance violation; and (2) the Anabolic Steroid Control Act of 1990 to modify the definition of "anabolic steroid" to include certain steroid precursors (including tetrahydrogestrinone (THG) and androstenedione) and to exclude dehydroepiandrosterone.

Directs the U.S. Sentencing Commission to review the Federal sentencing guidelines with respect to offenses involving anabolic steroids and consider amending such guidelines to provide for increased penalties.

Authorizes the Attorney General, upon the recommendation of the Secretary of Health and Human Services, to exempt from regulation under the Controlled Substances Act any compound, mixture, or preparation that contains any anabolic steroid that is intended for administration to a human being or an animal and that does not present any significant potential for abuse because of its concentration, preparation, formulation, or delivery system.

Directs the Secretary to prepare and submit a report to the House and Senate Judiciary Committees and the House Committee on Energy and Commerce evaluating the health risks associated with dietary supplements not scheduled under this Act which contain substances similar to those added to the list of controlled substances under this Act, including recommendations on whether such substances should be regulated as anabolic steroids.

Apr 2, 200418

Anabolic Steroid Control Act of 2004 - Amends the Controlled Substances Act to subject an offense of manufacturing, distributing, or possessing with intent to distribute an anabolic steroid within 1000 feet of a sports facility to twice the maximum penalty otherwise imposed for a controlled substance violation.

Directs the U.S. Sentencing Commission to review the Federal sentencing guidelines with respect to offenses involving anabolic steroids and consider amending such guidelines to provide for increased penalties.

Modifies the definition of "anabolic steroid" to include certain steroid precursors (including tetrahydrogestrinone (THG) and androstenedione) and to exclude dehydroepiandrosterone.

Authorizes the Attorney General, upon the recommendation of the Secretary of Health and Human Services, to exempt from regulation under such Act any compound, mixture, or preparation that contains any anabolic steroid that is intended for administration to a human being or an animal and that does not present any significant potential for abuse because of its concentration, preparation, formulation, or delivery system.

Directs the Secretary to prepare a report to the House and Senate Judiciary Committees evaluating the health risks associated with dietary supplements not addressed in this Act which contain substances similar to those added to the list of controlled substances under this Act.

Mar 1, 200400

Anabolic Steroid Control Act of 2004 - Amends: (1) the Controlled Substances Act to subject an offense of manufacturing, distributing, or possessing with intent to distribute an anabolic steroid within 1,000 feet of a sports facility to twice the maximum penalty otherwise imposed for a controlled substance violation; and (2) the Anabolic Steroid Control Act of 1990 to modify the definition of "anabolic steroid" to include certain steroid precursors (including tetrahydrogestrinone (THG) and androstenedione) and to exclude dehydroepiandrosterone.

Directs the U.S. Sentencing Commission to review the Federal sentencing guidelines with respect to offenses involving anabolic steroids and consider amending such guidelines to provide for increased penalties.

Authorizes the Attorney General, upon the recommendation of the Secretary of Health and Human Services, to exempt from regulation under such Act any compound, mixture, or preparation that contains any anabolic steroid that is intended for administration to a human being or an animal and that does not present any significant potential for abuse because of its concentration, preparation, formulation, or delivery system.